Clearview Capital exits behavioural healthcare platform through $610m muni bond-backed sale

Private equity firm Clearview Capital has agreed to exit US behavioural healthcare provider Advantage Behavioral Health (ABH) in a transaction financed through the municipal bond market, according to a report by Bloomberg.

The Connecticut-based buyout firm is selling the New Jersey-headquartered operator of mental health centres and sober-living facilities to nonprofit organisation QCF/I, Inc., which is funding the acquisition through a planned $610 million non-rated municipal bond issuance.

Under the terms of the deal, Clearview, together with ABH’s founders and management team, is expected to receive approximately $415m at closing, with the potential to earn an additional $100m if the business achieves agreed performance milestones.

ABH’s existing management team will remain in place following the acquisition, while the balance of the bond proceeds will be used for reserves and transaction costs.

The sale comes just over a year after Clearview recapitalised ABH alongside the company’s founders and senior executives.

QCF, a nonprofit organisation led by former municipal bond banker James Golden, has been building a portfolio of behavioural healthcare assets since 2024. Previous acquisitions include addiction treatment centres in New Jersey, a halfway house in Denver and a psychiatric hospital in Las Vegas.

The latest acquisition will add a network of more than 30 behavioural healthcare facilities across eight US states to its portfolio.

KeyBanc Capital Markets, which is underwriting the bond offering, is also advising on a growing pipeline of similar healthcare transactions. According to the bank, it is working on around a dozen comparable municipal bond financings with an aggregate value approaching $3bn.

Demand for behavioural healthcare assets has remained strong as providers seek to address growing need for mental health and addiction treatment services. KeyBanc estimates the US behavioural health market is worth approximately $320 billion.

ABH, which serves privately insured patients through in-person and telehealth services, expects to treat more than 500,000 patients annually. Based on current projections, the business is expected to generate around $170 million in annual revenue and approximately $78 million of EBITDA this year.

Forecasts prepared for the acquisition project EBITDA rising to about $90.8m in 2027 on revenue of approximately $192m, supported by continued expansion of the company’s Victory Bay addiction and mental health treatment centres.

However, the financing structure has attracted scrutiny from some municipal bond investors and analysts, who have questioned both the level of leverage and the relatively limited real estate backing underpinning the transaction. According to the offering documents, only around $14.4m of ABH’s valuation is represented by owned property, leaving investors primarily exposed to the operating performance of the business.